MX2017016028A - Formulaciones para el tratamiento de trastornos de la boca, garganta y tracto respiratorio. - Google Patents

Formulaciones para el tratamiento de trastornos de la boca, garganta y tracto respiratorio.

Info

Publication number
MX2017016028A
MX2017016028A MX2017016028A MX2017016028A MX2017016028A MX 2017016028 A MX2017016028 A MX 2017016028A MX 2017016028 A MX2017016028 A MX 2017016028A MX 2017016028 A MX2017016028 A MX 2017016028A MX 2017016028 A MX2017016028 A MX 2017016028A
Authority
MX
Mexico
Prior art keywords
throat
disorders
formulations
mouth
treatment
Prior art date
Application number
MX2017016028A
Other languages
English (en)
Inventor
Mehta Raman
Original Assignee
Mehta Raman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mehta Raman filed Critical Mehta Raman
Publication of MX2017016028A publication Critical patent/MX2017016028A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a formulaciones que contienen una combinación de extractos de Curcuma longa, Punica granatum y Zingiber officinale, actuando sinérgicamente en el tratamiento y prevención de trastornos de la boca, garganta y tracto respiratorio; la formulación es especialmente activa en trastornos de origen bacteriano, por ejemplo los que ocurren en pacientes afectados por resfriados y gripes comunes y sus complicaciones. Las presentes formulaciones son particularmente útiles en la reducción de incidencia de irritación de la garganta y sus infecciones y en la eliminación del uso de antibióticos, especialmente entre niños y adultos mayores o ancianos.
MX2017016028A 2015-06-10 2016-06-10 Formulaciones para el tratamiento de trastornos de la boca, garganta y tracto respiratorio. MX2017016028A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15171354.2A EP3103464A1 (en) 2015-06-10 2015-06-10 Formulations for the treatment of disorders of the mouth, throat and respiratory tract
PCT/IB2016/000795 WO2016198943A1 (en) 2015-06-10 2016-06-10 Formulations for the treatment of disorders of the mouth, throat and respiratory tract

Publications (1)

Publication Number Publication Date
MX2017016028A true MX2017016028A (es) 2018-04-13

Family

ID=53396312

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017016028A MX2017016028A (es) 2015-06-10 2016-06-10 Formulaciones para el tratamiento de trastornos de la boca, garganta y tracto respiratorio.

Country Status (14)

Country Link
US (1) US10758587B2 (es)
EP (2) EP3103464A1 (es)
JP (1) JP6966998B2 (es)
KR (1) KR20180030970A (es)
CN (1) CN108040468B (es)
AU (1) AU2016276145B2 (es)
BR (1) BR112017026417B1 (es)
ES (1) ES2730088T3 (es)
HU (1) HUE044731T2 (es)
MX (1) MX2017016028A (es)
PL (1) PL3307293T3 (es)
PT (1) PT3307293T (es)
TR (1) TR201908938T4 (es)
WO (1) WO2016198943A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3103465A1 (en) * 2015-06-10 2016-12-14 Raman Mehta Formulations for the treatment of mucosal lesions
KR102224051B1 (ko) * 2019-04-04 2021-03-09 한국 한의학 연구원 건강 추출물을 유효성분으로 포함하는 중화항체 생성율 증진용 조성물
IT202000018949A1 (it) 2020-08-03 2022-02-03 Arterra Bioscience S P A Estratto derivato da bucce di punica granatum per la prevenzione e il trattamento di infezioni virali
IT202000026566A1 (it) * 2020-11-06 2022-05-06 Herbal E Antioxidant Derivatives Srl Ed In Forma Abbreviata H&Ad Srl Combinazioni di antivirali e antimicrobici naturali, loro uso e formulazioni che le contengono
WO2023037299A1 (en) * 2021-09-09 2023-03-16 Integria Healthcare (Australia) Pty Limited Anti-inflammatory compositions comprising ginger and turmeric
TR2022000292A2 (tr) 2022-01-11 2022-02-21 Tuerkiye Bilimsel Veteknolojik Arastirma Kurumu SARS-CoV-2 Virüsüne Karşı Koruyucu Pastil/Çiğneme Tableti Üretimi

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596313B2 (en) * 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it
JP2007153888A (ja) * 2005-11-14 2007-06-21 Kanebo Foods Ltd 体内浄化用組成物、それを用いた食品、入浴剤、化粧料、製剤及び有害金属排泄促進剤
US20090175971A1 (en) * 2008-01-08 2009-07-09 Mark Dreher Method of using composition comprising pomegranate extracts against the common cold
DE202009002126U1 (de) * 2009-02-13 2009-04-16 Orthomol Pharmazeutische Vertriebs Gmbh Spurenelement enthaltende Zusammensetzung
KR101077920B1 (ko) * 2009-07-08 2011-10-31 한국생명공학연구원 울금 추출물을 포함하는 인플루엔자 바이러스 감염의 예방 및 치료용 조성물 및 뉴라미니데이즈 활성의 억제용 조성물
MY152711A (en) * 2009-12-04 2014-11-28 Colgate Palmolive Co Oral compositions containing a combination of natural extracts and related methods
IT1402018B1 (it) * 2010-10-11 2013-08-28 Indena Spa Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
JP2013001666A (ja) * 2011-06-14 2013-01-07 Yasuharu Omura 栄養剤組成物
CN102670588B (zh) 2012-05-04 2013-11-20 中国科学院上海生命科学研究院湖州营养与健康产业创新中心 鞣花酸用于制备抗病毒药物的应用
CN103638502B (zh) 2013-12-12 2015-07-01 苏振华 一种治疗白塞病的药物及其制备方法
CN104524508A (zh) 2014-12-24 2015-04-22 赵红 一种治疗消化性溃疡的中药及其制备方法

Also Published As

Publication number Publication date
US10758587B2 (en) 2020-09-01
EP3103464A1 (en) 2016-12-14
PT3307293T (pt) 2019-06-12
EP3307293B1 (en) 2019-03-20
JP2018519361A (ja) 2018-07-19
ES2730088T3 (es) 2019-11-08
HUE044731T2 (hu) 2019-11-28
JP6966998B2 (ja) 2021-11-17
EP3307293A1 (en) 2018-04-18
CN108040468A (zh) 2018-05-15
TR201908938T4 (tr) 2019-07-22
PL3307293T3 (pl) 2019-11-29
CN108040468B (zh) 2021-08-20
WO2016198943A1 (en) 2016-12-15
KR20180030970A (ko) 2018-03-27
AU2016276145A1 (en) 2017-12-21
BR112017026417B1 (pt) 2021-04-27
US20180169175A1 (en) 2018-06-21
AU2016276145B2 (en) 2022-05-26

Similar Documents

Publication Publication Date Title
MX2017016028A (es) Formulaciones para el tratamiento de trastornos de la boca, garganta y tracto respiratorio.
MX2021004110A (es) Composiciones farmaceuticas que comprenden n-(3,5- dimetoxifenil)-n'-(1-metiletil)-n-[3-(1-metil-1h- pirazol-4-il)quinoxalin-6-il]etano-1,2-diamina.
MX2016010179A (es) Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer.
BR112018014654A2 (pt) cepa inovadora de bactérias probióticas e composições e usos da mesma
JP2016069317A5 (ja) 腎不全進行抑制剤、腎不全予防剤、尿毒症治療剤、インドキシル硫酸産生阻害剤、心血管系疾患予防剤、及び食品組成物
ZA202109296B (en) Formulations and preparations for prevention and treatment of covid-19 and flu therefor
PH12015502274A1 (en) Lozenge for treating a sore throat, hoarseness, and associated dry cough and for treating inflammatory diseases of the oral cavity and of the pharynx
WO2019220329A8 (en) Probiotic strain lactobacillus kefiri sgl 13 and use thereof for the prevention and treatment of intestinal inflammation and in the prevention of intestinal neoplasms
WO2019155360A3 (en) Pharmaceutical composition for treating bacterial and viral infections
TR201721700A2 (tr) Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari
MX2017013433A (es) Composiciones antibacterianas.
BR112018072177A2 (pt) composição farmacêutica, recipiente, e, métodos para tratar e prevenir congestão nasal, infecções virais do trato respiratório e/ou inflamação da garganta
MX2023000899A (es) Administracion de beta-hidroxibutirato y compuestos relacionados en humanos para el tratamiento y/o prevencion de enfermedades respiratorias.
WO2016159583A3 (ko) 지구자 추출물을 유효성분으로 함유하는 선천면역 증진 및 항바이러스용 조성물
EP4017496A4 (en) FORMULATIONS FOR THE PREVENTION AND/OR TREATMENT OF PERIPHERAL NEUROPATHY AND ITS ASSOCIATED DISEASES
WO2016159584A3 (ko) 상지 또는 상백피 추출물을 유효성분으로 함유하는 선천면역 증진 및 항바이러스용 조성물
MX2017016029A (es) Formulaciones para el tratamiento de lesiones de la mucosa.
WO2018078599A3 (en) Composition for the preventive or curative treatment of liver disorders
JP2016003187A5 (es)
MX2017013434A (es) Composiciones antibacterianas.
IL297042A (en) Synergistic mixtures of the drug compounds gabapentin and ketoprofen and their medical use
MX2021000950A (es) Composiciones que comprenden un extracto de arandano americano y fosfolipidos.
ZA202210027B (en) Compositions of vitamin a palmitate, processes for their preparation, uses and methods comprising them
ZA202104321B (en) Aqueous paediatric retinol formulations
MX2023001621A (es) Composiciones farmacéuticas para el tratamiento y la prevención de infecciones de las vías urinarias.